Catalyst Wire Dossier Catalyst Wire Dossier

mRNA-1893 (Zika vaccine)

mRNA-1893 · Moderna, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for mRNA-1893 (Zika vaccine), covering 2024-06-17 to 2024-06-17. Get the full timeline:

Most recent: Clinical Trial Update: Safety, Tolerability, and Immunogenicity of Zika Vaccine mRNA-1893 in Healthy Flavivirus Seropositive and Seronegative Adults [Phase 1]

See pricing